Narayana Hrudayalaya Ltd Q2 FY26: The ₹5,961 Cr Lifesaver with a ₹41,717 Cr Market Cap and an Appetite for Acquisitions That Would Put Ambani’s Shopping Spree to Shame

1. At a Glance

Welcome to the hospital chain that turned healthcare into a scalable business model and still calls itself “affordable.” Narayana Hrudayalaya Ltd — or “NH” if you’re too breathless to pronounce the whole name — is a ₹41,717 crore market cap healthcare giant that makes ₹850 crore in annual profit and still charges less than your neighborhood Apple Store for an ECG.

The latest quarterly results (Q2 FY26) came in like a healthy patient’s pulse — strong and steady. Revenue jumped to ₹1,644 crore (up 20.3% YoY), while PAT surged 29.6% to ₹258 crore. EPS is now at a cool ₹12.64, taking annualized EPS to nearly ₹50. With a stock P/E of 49.1 and a return on equity of 24.2%, this is a hospital chain that’s operating like a private equity fund in a lab coat.

From cardiac surgeries to oncology, from Bangalore to the Cayman Islands — NH’s 40 facilities and 5,789 beds across India and abroad are running at a pace that would make even their ventilators gasp. And just when investors thought this was a simple Indian healthcare play, they went and acquired the UK-based Practice Plus Group Hospitals for £188.78 million (because why stop at saving Indian hearts when you can fix the British NHS too?).

2. Introduction

Narayana Hrudayalaya Ltd is proof that capitalism and compassion can indeed co-exist — as long as you bill smartly and expand aggressively. Founded by the legendary Dr. Devi Shetty, this is not your average hospital chain; it’s a healthcare conglomerate that figured out how to treat heart disease and investor FOMO at the same time.

The company started off with the noble mission of “affordable healthcare for all.” Two decades later, it has affordable branding, premium hospitals, and a Cayman Island outpost that screams “medical tourism with tax efficiency.”

With a network of 40 healthcare facilities and over 5,700 operational beds, NH is now India’s fourth-largest hospital chain by revenue — trailing only behind Apollo, Max Healthcare, and Fortis. But while Apollo loves luxury and Fortis loves restructuring, NH loves efficiency — the kind that converts a patient’s ₹100,000 bill into a 24% operating profit margin.

What’s even more amusing? Their diversification strategy. While others build hospitals, NH buildssubsidiaries— including one calledMedha AI Pvt Ltdthat will handle IT, software, and AI-based healthcare tools. Because who doesn’t want a bot that diagnoses you faster than your family doctor replies on WhatsApp?

And just in case you thought hospitals were boring, remember — this is the same company that just dropped ₹1,900 crore on a British hospital chain. It’s basically Dr. Devi Shetty saying, “If we can fix your hearts, we can also fix your healthcare systems — even in the UK.”

3. Business Model – WTF Do They Even Do?

Let’s break it down before we go into cardiac arrest. Narayana Hrudayalaya is amulti-specialty and super-specialty hospital chainwhose business model revolves around three magic words: scale, efficiency, and empathy (with a strong emphasis on the first two).

They earn revenue through four core streams:

  1. Cardiac Sciences (32%)– The heart of the business, literally. Everything from pediatric cardiac surgeries to robotic heart interventions.
  2. Oncology (15%)– Because cancer care is the unfortunate recurring customer segment in modern healthcare.
  3. Medicine & GI Sciences (13%)– Handles the chronic and lifestyle diseases that millennials bring as dowry.
  4. Renal Sciences (10%)– Kidney transplants and dialysis — the “subscription business” of the medical world.

The rest is spread across neurosciences, orthopedics, pulmonology, and ENT.

Thebusiness mixsays it all: 70% of revenue comes from owned hospitals, 27% from operated hospitals, and the rest from heart centers and ancillary ventures. Translation: They’re mostly landlords who also happen to operate ICUs.

Payor mix? 45% domestic walk-ins, 29% insured patients, 20% government schemes, and 7% international tourists who probably confuse “Health City Bangalore” with a five-star resort until they see the surgical lights.

Their footprint spans19 owned/operated hospitals in India, 2 heart centers, 18 clinics, and 1 Cayman Islands hospital. That adds up to a total of 40 facilities and a healthy bed capacity of 5,789.

4. Financials Overview

MetricLatest Qtr (Sep 2025)YoY Qtr (Sep 2024)Prev Qtr (Jun 2025)YoY %QoQ %
Revenue (₹ Cr)1,6441,3671,50720.3%9.1%
EBITDA (₹ Cr)40130933729.8%19.0%
PAT (₹ Cr)25819919729.6%31.0%
EPS (₹)12.649.729.6230.0%31.4%

If hospitals could brag on Instagram, NH’s numbers would have blue ticks. A YoY revenue growth of 20.3% and a 29.6% PAT surge is like the patient walking out of ICU doing the moonwalk.

The OPM of 24% is stellar, considering this is a sector where most margins collapse under the weight

of capex and compliance.

Annualizing the latest EPS (₹12.64 x 4 = ₹50.56), the P/E recalculates to around40.4x, cheaper than Apollo’s 63x and Fortis’ 69x. Not bad for a hospital that’s also buying its way into the UK.

5. Valuation Discussion – Fair Value Range (Educational Only)

Let’s run through three standard models.

A) P/E Method

  • EPS (annualized): ₹50.56
  • Peer P/E range (Apollo 63.6x, Max 81.6x, Fortis 69x)
  • Conservative fair range = 40x to 55x→Fair Value Range: ₹2,022 – ₹2,780

B) EV/EBITDA Method

  • EV = ₹43,539 Cr
  • EBITDA (FY25): ₹1,403 Cr
  • EV/EBITDA = 31x (high, but justified for growth)
  • Applying a fair multiple range of 25x–30x→Fair Value Range: ₹1,750 – ₹2,100

C) DCF SnapshotAssuming 12% topline CAGR, 24% EBITDA margin, and 10% discount rate, intrinsic value clusters around₹2,200 – ₹2,400per share.

📜 Disclaimer:This fair value range is for educational purposes only and isnot investment advice. Consult your wallet (and doctor) before proceeding.

6. What’s Cooking – News, Triggers, Drama

Narayana Hrudayalaya’s announcement section lately reads like a Netflix drama. Let’s recap the top plot twists of 2025:

  • UK Takeover:AcquiredPractice Plus Group Hospitalsfor GBP 188.78 million (~₹1,900 Cr). It’s like Dr. Shetty saying, “NHS, scoot over — I got this.” The acquisition adds ₹300 crore+ EBITDA to the group from Day 1.
  • Mega Expansion:Foundation stone laid for an1,100-bed hospital in Kolkata, because apparently Kolkata doesn’t have enough reasons to queue.
  • Bengaluru Land Purchase:Acquired3 acresin Bengaluru for a new hospital — because why rent when you can own the ICU view?
  • Vaishno Devi Hospital Agreement:NH signed an agreement with theShri Mata Vaishnodevi Charitable Societyto operate a specialty hospital — divine intervention meets surgical precision.
  • Cayman JV:Their Cayman subsidiary entered ajoint venture for cancer treatment centers in India— because nothing says synergy like cross-border chemo.
  • Medha AI Pvt Ltd:Their new AI venture aims to “develop software solutions and testing tools.” Translation: they’re teaching AI to say, “Your liver enzymes are high” in 15 languages.

And if you’re wondering about that BSE clarification? Yes, they had to confirm they weren’t hiding insider news — the stock volume just had a pulse of its own.

7. Balance Sheet (₹ Cr)

MetricMar 2023Mar 2024Sep 2025
Total Assets4,1705,6337,742
Net Worth (Equity + Reserves)2,1312,8834,059
Borrowings8841,6272,340
Other Liabilities1,1551,1231,342
Total Liabilities4,1705,6337,742
To Read Full 16 Point ArticleBecome a member
Become a member
To Read Full 16 Point ArticleBecome a member

Leave a Comment

error: Content is protected !!